ArrowMark Colorado Holdings’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $78.2M | Sell |
|
|||||
|
2021
Q2 | $85.4M | Sell |
|
|||||
|
2021
Q1 | $88.4M | Buy |
|
|||||
|
2020
Q4 | $84M | Buy |
|
|||||
|
2020
Q3 | $69.5M | Sell |
|
|||||
|
2020
Q2 | $87.4M | Sell |
|
|||||
|
2020
Q1 | $56.1M | Sell |
|
|||||
|
2019
Q4 | $78.6M | Buy |
|
|||||
|
2019
Q3 | $62.8M | Buy |
|
|||||
|
2019
Q2 | $55.9M | Buy |
|
|||||
|
2019
Q1 | $53.7M | Buy |
|
|||||
|
2018
Q4 | $46.5M | Buy |
|
|||||
|
2018
Q3 | $55.8M | Buy |
|
|||||
|
2018
Q2 | $49.5M | Buy |
|
|||||
|
2018
Q1 | $53.5M | Sell |
|
|||||
|
2017
Q4 | $62.1M | Sell |
|
|||||
|
2017
Q3 | $58.8M | Buy |
|
|||||
|
2017
Q2 | $54M | Buy |
|
|||||
|
2017
Q1 | $40.1M | Sell |
|
|||||
|
2016
Q4 | $41.8M | Buy |
|
|||||
|
2016
Q3 | $29.6M | Buy |
|
|||||
|
2016
Q2 | $22.7M | Buy |
|
|||||
|
2016
Q1 | $19.8M | Buy |
|
|||||
|
2015
Q4 | $20.1M | Buy |
|
|||||
|
2015
Q3 | $17.5M | Buy |
|
|||||
|
2015
Q2 | $17.7M | Sell |
|
|||||
|
2015
Q1 | $17.3M | Buy |
|
|||||
|
2014
Q4 | $13.3M | Buy |
|
|||||
|
2014
Q3 | $13.6M | Buy |
|
|||||
|
2014
Q2 | $14.7M | Buy |
|
|||||
|
2014
Q1 | $615K | Buy |
|